Literature DB >> 10682183

Classification and epidemiology of headache.

R B Lipton1, P Goadsby, S D Silberstein.   

Abstract

Headache disorders are remarkably common. Like back pain, headache is a symptom that has a broad range of possible causes. Diagnosis of primary headache disorders (migraine, tension-type headache, cluster headache) depends on systematic exclusion of secondary disorders and systematic identification of the specific features of the primary disorders. Thus, migraine should be viewed as an episodic syndrome of pain, involving intracranial structures associated with other neurologic disturbances. Because of the large number of potential etiologies, clinicians must approach headache classification systematically. In this chapter, we provide an overview of headache classification followed by discussions of epidemiology.

Entities:  

Mesh:

Year:  1999        PMID: 10682183     DOI: 10.1016/s1098-3597(99)90035-2

Source DB:  PubMed          Journal:  Clin Cornerstone        ISSN: 1873-4480


  5 in total

Review 1.  Fibromyalgia, fatigue, and headache disorders.

Authors:  Mario F P Peres
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

Review 2.  Appropriate use of neuroimaging in headache.

Authors:  Deena E Kuruvilla; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2015-06

Review 3.  Migraine, tension-type headache, and transformed migraine.

Authors:  Mario F P Peres; Andre Leite Gonçalves; Abouch Krymchantowski
Journal:  Curr Pain Headache Rep       Date:  2007-12

4.  Primary headaches in patients with generalized anxiety disorder.

Authors:  Juliane P P Mercante; Mario F P Peres; Márcio A Bernik
Journal:  J Headache Pain       Date:  2011-02-05       Impact factor: 7.277

5.  Migraine headaches among university students using ID Migraine test as a screening tool.

Authors:  Serdar Oztora; Osman Korkmaz; Nezih Dagdeviren; Yahya Celik; Ayse Caylan; Mehmet S Top; Talip Asil
Journal:  BMC Neurol       Date:  2011-08-19       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.